Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Dragonfly Energy Q1 2025 Earnings Call - Stevens Transport Lands $3M Heavy-Duty Order
Dragonfly Energy reported Q1 2025 results that beat top-line guidance, though the broader RV market remains soft. The real story is the commercial inflection in heavy-duty trucking. Stevens Transport,...
- Dragonfly Energy reported Q1 2025 net sales of $9.7 million, beating guidance, driven by $5.8 million in OEM revenue and $3.7 million in DTC sales.
- Stevens Transport placed a landmark $3 million purchase order for nearly 500 trucks, covering Dragonfly's full heavy-duty trucking product portfolio including the DualFlow Power Pack and All-Electric APU.
- The Stevens order represents a critical inflection point, transitioning Dragonfly from pilot deployments to fleet-wide commercial adoption in the heavy-duty trucking sector.
- +7 more takeaways
CV Sciences Q1 2026 Earnings Call - Near Cash Flow Breakeven as Company Pivots Beyond CBD
CV Sciences reported Q1 2026 revenue of $3.2 million, a modest 3% sequential decline, but the real story lies in the margin expansion and cost discipline. Gross margins held at 48.9% despite rising in...
- Revenue of $3.2 million in Q1 2026, down 3% sequentially and 11% year-over-year, driven by a 12% decline in unit sales.
- Gross margin held steady at 48.9%, up from 46.0% in Q1 2025, supported by lower product costs and insourcing manufacturing.
- Operating expenses dropped 13.3% year-over-year to $1.9 million, reflecting structural cost reductions in legal, marketing, and admin.
- +9 more takeaways
Sangamo Therapeutics Q1 2026 Earnings Call - FDA Clears Path for Accelerated Fabry Approval Without Confirmatory Trial
Sangamo Therapeutics advanced its rolling BLA submission for ST-920 in Fabry disease, with the FDA confirming that a confirmatory trial is unnecessary and that 104-week data can serve as traditional a...
- Rolling BLA submission for ST-920 in Fabry disease is underway, with the first two modules already filed and the CMC module in progress. The company targets a complete submission by summer, contingent on securing additional funding.
- The FDA recently reaffirmed that ST-920 can receive accelerated approval based on mean annualized eGFR slope at 52 weeks across all 32 dosed patients, and a confirmatory trial is not required for traditional approval.
- 104-week data from all patients will be submitted when seeking traditional approval, with the last patient reaching the 2-year milestone in April and data analysis currently in progress.
- +7 more takeaways
Newsmax Q1 2026 Earnings Call - Affiliate Fees and International Licensing Drive Revenue Growth Amidst Streaming Expansion
Newsmax delivered a strong start to 2026 with Q1 2026 revenue of $51.7 million, up 14% year-over-year, driven by a 20.8% surge in broadcasting revenue fueled by affiliate fee growth and international ...
- Total revenue reached $51.7 million, up 14% year-over-year, with broadcasting revenue surging 20.8% to $43.7 million.
- Affiliate fee revenue jumped 75.2% year-over-year to $13 million, driven by new contractual relationships and rate increases from late 2025.
- Digital advertising revenue declined 12.7% to $8 million, reflecting a tougher comparison after the elevated demand of the 2024 election cycle.
- +7 more takeaways
Vuzix Corporation Q1 2026 Earnings Call - OEM and Waveguide Momentum Builds Despite Revenue Dip
Vuzix reported Q1 2026 revenue of $1.4 million, down 12% year-over-year, driven by lower M400 unit sales. However, the company signaled accelerating momentum in its two core growth engines: OEM smart ...
- Total revenue fell 12% year-over-year to $1.4 million, dragged by lower M400 smart glasses sales.
- Engineering services revenue climbed 36% to $0.35 million, signaling growing customer-funded development work.
- Gross loss widened to $0.4 million from $0.3 million as fixed manufacturing costs were less absorbed by lower sales.
- +7 more takeaways
Morgan Stanley Direct Lending Fund Q1 2026 Earnings Call - Spreads Widen and Dividend Coverage Holds as Yield Compression Halts
Morgan Stanley Direct Lending Fund (MSDL) reported a modest decline in net investment income to $0.47 per share in Q1 2026, driven by the pass-through of the December Fed rate cut. Despite this, earni...
- Net investment income declined modestly to $0.47 per share, down from $0.49 in Q4 2025, primarily due to the December Fed rate cut flowing through the portfolio.
- Dividend coverage remained strong at 104%, with a $0.45 per share distribution declared for Q2 2026, well-supported by underlying portfolio performance.
- Yield compression halted for the first time in eight quarters, as spreads widened by 25 basis points and new loan terms became more lender-friendly.
- +7 more takeaways
Construction Partners Q2 FY2026 Earnings Call - Raised FY2026 Outlook on Record Backlog and Sunbelt Momentum
Construction Partners delivered a robust Q2 FY2026, with revenue jumping 35% year-over-year to $769.2 million and adjusted EBITDA climbing 35% to $93.3 million. The company is raising its full-year fi...
- Full-year fiscal 2026 guidance raised across all metrics: Revenue now expected at $3.59 billion to $3.65 billion, and Adjusted EBITDA at $552 million to $564 million.
- Q2 revenue surged 35% to $769.2 million, driven by 11% organic growth and 24% acquisitive growth, with adjusted EBITDA margin expanding to 12.1%.
- Record backlog stands at $3.14 billion, with approximately 80-85% of the next 12 months of contract revenue already secured.
- +7 more takeaways
Embraer Q1 2026 Earnings Call - Record Backlog and Defense Momentum Offset Margin Pressure
Embraer delivered its strongest first quarter on record, driven by a surge in executive aviation and defense revenue. The company posted $1.4 billion in net revenue, up 31% year-over-year, while pushi...
- 1. Record Q1 2026 Revenue: Net revenues surged 31% year-over-year to $1.4 billion, marking the highest first-quarter revenue in the company's history.
- 2. Backlog Hits New High: The total backlog reached BRL 32 billion, a 22% increase year-over-year. Commercial aviation backlog alone jumped 50% to BRL 15 billion, fueled by a strong book-to-bill ratio.
- 3. Defense & Security Surge: Defense revenue grew 62% to $227 million, driven by higher KC-390 revenue recognition and A-29 production. The segment posted a healthy 17% adjusted EBIT margin.
- +7 more takeaways
BrasilAgro Q3 2025 Earnings Call - Net Losses Mount as Geopolitical Shocks and El Niño Threaten Margins
BrasilAgro reported a BRL 76 million net loss for the first nine months of the 2025/26 period, a sharp reversal from the BRL 76 million profit recorded in the same timeframe last year. The deteriorati...
- BrasilAgro reported a BRL 76 million net loss for the first nine months of the 2025/26 period, reversing a BRL 76 million profit from the prior year.
- Adjusted EBITDA fell to BRL 42.8 million, down significantly from BRL 195 million in the same period last year, driven by lower sugarcane volumes and cotton price weakness.
- Sugarcane production dropped to 971,000 tons for the 2025/26 harvest, compared to 1,341,000 tons in the prior year, due to frost damage and regional burns.
- +7 more takeaways
Reinsurance Group of America Q1 2026 Earnings Call - Favorable Claims Experience Drives Strong Start, Capital Deployment Remains Disciplined
Reinsurance Group of America delivered a robust first quarter for 2026, reporting pre-tax adjusted operating income of $611 million, or $6.97 per share after tax. The quarter was defined by broad-base...
- RGA reported pre-tax adjusted operating income of $611 million ($6.97 per share after tax), marking a strong start to 2026 with broad-based performance across regions and products.
- Economic claims experience was favorable by $117 million in Q1, with cumulative favorable experience since 2023 totaling $343 million, underscoring the strength of pricing and risk selection.
- The company deployed $338 million into in-force transactions during the quarter, maintaining a disciplined approach to capital allocation and focusing on high-risk-reward opportunities.
- +7 more takeaways